Announcements Trials
Browse Landscape

Phase

Phase 2 63Phase 1 27Phase 1/2 15Phase NA 14Phase 3 6Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 1

Status

Terminated 7Completed 7Recruiting 6Active not recruiting 6Withdrawn 3Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Breast Neoplasms 15Neoplasms 11Pancreatic Neoplasms 10Prostatic Neoplasms 7Glioma 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Sarcoma 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Brain Neoplasms 3Pain, Postoperative 2Lymphoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Depression 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2

Interventions

Radiosurgery 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Neoplasm Metastasis × Clear all
NCT04294875 2024-03-06

MPT0B64

J Ints Bio

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasm Metastasis

NCT03671720 2024-02-07

Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden

Capital Medical University

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasm Metastasis

NCT05728372 2023-10-10

64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation

City of Hope Medical Center

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡